Standard BioTools Inc. ( LAB) - Stock Earnings
LAB Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 3, 2026, midnight | — / — | — | — / — | — |
LAB Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 19.3 million USD | 23.8 million USD |
| 2026Q1 | -45.2 million USD | 21.1 million USD |
| 2026Q2 | -26.8 million USD | 20.1 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
LAB Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -74.7 million USD | 106.3 million USD |
| 2024 | -138.9 million USD | 174.4 million USD |
| 2025 | -74.9 million USD | 85.3 million USD |
| 2026 Est. | — | — |
LAB
Price: $0.67
52 week price:
Earnings Per Share: -0.13 USD
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Market Capitalization: 291.5 million